The token represents a significant advancement in brain health through its association with Percepta®, a patented natural dietary supplement designed to enhance cognitive function. This innovative product combines potent ingredients, including PTI-00703® Cat’s claw and MemorTea®, a specialized oolong tea extract, aimed at addressing cognitive decline, memory loss, and neurodegenerative diseases. Cerebrum DAO is committed to developing both immediate and long-term solutions in the realm of brain health. The global market for brain health supplements exceeds $8.6 billion, yet many existing products lack robust clinical evidence. Percepta® stands out with strong patent protection and promising research outcomes, positioning it as a potential leader in this rapidly growing market. The unique tokenization of Percepta®'s patent portfolio and the first-ever tokenized crowdsale for a clinical evidence study underscore its innovative approach. Successful outcomes from this study could pave the way for future trials and potentially lead to FDA botanical drug status, which would significantly enhance access to brain health solutions on a global scale. By investing in this token, stakeholders contribute to the advancement of scientific research and the potential development of effective treatments that could revolutionize brain health management. The initiative not only aims to improve individual cognitive health but also aspires to reshape the landscape of brain health supplements with verified efficacy.